Other studies have also shown that CREPT is overexpressed in CRC, contributes to tumor progression and cell proliferation, is positively correlated with the efficacy of 5-FU treatment, and can serve as a valuable prognostic biomarker for CRC patients [23]. Here, RPRD1B is linked to neoplasm.